DEFA14A: ZSPACE Sets Annual Meeting, Seeks Shareholder Approvals

ZSPACE, Inc. announced its annual stockholder meeting for October 15, 2025, seeking approval for director elections, auditor ratification, and significant stock issuances related to institutional investments.

Summary

• The Annual Meeting of Stockholders for ZSPACE, Inc. will be held on Wednesday, October 15, 2025, at 9:00 AM Pacific Time at 55 Nicholson Lane, San Jose, California.
• Stockholders of record as of August 21, 2025, are eligible to vote.
• Shareholders will vote on the election of four Class I directors: Joanna Morris, Abhay Pande, Angela Prince, and Jane Swift.
• The ratification of UHY LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, is also on the agenda.
• Approval is sought for the issuance of common stock in connection with a Convertible Promissory Note, dated April 11, 2025, issued to an institutional investor, as required by Nasdaq Listing Rule 5635(d).
• Approval is also sought for the issuance of common stock in connection with a Common Stock Purchase Agreement, dated July 7, 2025, with an institutional investor, as required by Nasdaq Listing Rule 5635(d).
• An amendment to the Amended and Restated Certificate of Incorporation to allow for stockholder action by written consent will be voted upon.
• Shareholders will consider approving the adjournment of the annual meeting, if necessary, to solicit further proxies.
• The Board of Directors recommends a vote 'FOR' on all proposals (1, 2, 3, 4, 5, and 6).

Sentiment

Score: 6

Explanation: The filing is primarily procedural for an annual meeting, but the underlying proposals for capital raises through institutional investors are a positive signal for the company's funding, balanced by the potential for shareholder dilution. The board's unanimous recommendation for all proposals adds a layer of confidence.

Positives

• The company is securing capital through a Convertible Promissory Note and a Common Stock Purchase Agreement with institutional investors, indicating investor confidence and providing potential funding for operations.
• The Board of Directors unanimously recommends approval for all key proposals, including director elections, auditor ratification, and the capital-raising initiatives.

Negatives

• The issuance of shares of common stock in connection with the Convertible Promissory Note and Common Stock Purchase Agreement will likely result in dilution for existing shareholders.

Risks

• Failure to obtain shareholder approval for the issuance of common stock related to the Convertible Promissory Note and Common Stock Purchase Agreement could impact the company's financing agreements and compliance with Nasdaq Listing Rule 5635(d).
• The issuance of additional common stock will dilute the ownership percentage of current shareholders.
• The amendment to allow stockholder action by written consent could potentially alter the balance of power between the board and shareholders, which may introduce governance risks depending on future shareholder activism.

Future Outlook

The filing indicates the company is actively securing institutional investment to support its operations, suggesting a focus on strengthening its financial position and potentially funding future growth initiatives, contingent on shareholder approvals.

Management Comments

• The Board of Directors recommends a vote 'FOR' on Proposals 1, 2, 3, 4, 5, and 6.

Industry Context

This filing reflects a common practice for publicly traded companies to hold annual meetings for corporate governance matters and to seek shareholder approval for significant financial transactions, particularly those involving equity issuance that could impact capital structure and compliance with listing rules. The reliance on institutional investors for capital raises is a typical strategy for growth-oriented companies.

Corporate Governance

Stakeholder Impact

• Shareholders will be directly impacted by the voting outcomes, particularly regarding the election of directors, the potential dilution from stock issuances, and changes to corporate governance.
• Institutional investors involved in the Convertible Promissory Note and Common Stock Purchase Agreement will become significant stakeholders, influencing the company's capital structure and future direction.

Next Steps

• Stockholders are encouraged to review proxy materials and vote on the proposals.
• The Annual Meeting of Stockholders will be held on October 15, 2025, to vote on the outlined proposals.
• If necessary, the annual meeting may be adjourned to permit further solicitation and voting of proxies.

Key Dates

Recommendation

This filing is primarily a procedural proxy statement for an annual meeting, not a direct financial results announcement. While the proposed capital raises with institutional investors are significant and generally positive for the company's funding, they also introduce potential dilution for existing shareholders. An investor would need more detailed financial information, such as the terms of the convertible note and stock purchase agreement, the company's current financial performance, and its strategic plans, to make a more definitive 'buy' or 'sell' decision. Therefore, a 'hold' recommendation is appropriate, pending further financial disclosures and a deeper analysis of the dilution impact versus the benefits of the capital infusion.

Keywords

ZSPACE, proxy statement, annual meeting, corporate governance, stock issuance, convertible note, common stock purchase agreement, Nasdaq Listing Rule 5635(d), director election, auditor ratification, shareholder vote